CapsoVision Profit Margin 2025-2025 | CV
Current and historical gross margin, operating margin and net profit margin for CapsoVision (CV) over the last 10 years. Profit margin can be defined as the percentage of revenue that a company retains as income after the deduction of expenses. CapsoVision net profit margin as of September 30, 2025 is 0%.
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Information Systems | $0.281B | $0.000B |
| CapsoVision Inc. is a commercial-stage medical technology company which develops advanced imaging and artificial intelligence technologies which are deployed in its capsule endoscopy solutions. CapsoVision Inc. is based in SARATOGA, Calif. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Veeva Systems (VEEV) | United States | $38.335B | 44.34 |
| Tempus AI (TEM) | United States | $12.322B | 0.00 |
| Doximity (DOCS) | United States | $8.258B | 34.00 |
| Hims & Hers Health (HIMS) | United States | $7.362B | 59.89 |
| IRhythm Technologies (IRTC) | United States | $5.445B | 0.00 |
| Hinge Health (HNGE) | United States | $3.816B | 0.00 |
| Privia Health (PRVA) | United States | $2.881B | 180.15 |
| Inspire Medical Systems (INSP) | United States | $2.816B | 46.60 |
| Heartflow (HTFL) | United States | $2.707B | 0.00 |
| 10x Genomics (TXG) | United States | $2.506B | 0.00 |
| Omnicell (OMCL) | United States | $2.297B | 46.96 |
| Azenta (AZTA) | United States | $1.726B | 70.83 |
| Enovis (ENOV) | United States | $1.541B | 8.09 |
| Schrodinger (SDGR) | United States | $1.373B | 0.00 |
| Clover Health Investments (CLOV) | United States | $1.364B | 0.00 |
| Butterfly Network (BFLY) | United States | $1.079B | 0.00 |
| Phreesia (PHR) | United States | $1.033B | 0.00 |
| Fulgent Genetics (FLGT) | United States | $0.870B | 0.00 |
| Talkspace (TALK) | United States | $0.661B | 133.00 |
| Standard BioTools (LAB) | United States | $0.581B | 0.00 |
| Claritev (CTEV) | United States | $0.528B | 0.00 |
| Evolent Health (EVH) | United States | $0.463B | 0.00 |
| Zepp Health (ZEPP) | Netherlands | $0.387B | 0.00 |
| Carlsmed (CARL) | United States | $0.384B | 0.00 |
| SOPHiA GENETICS SA (SOPH) | Switzerland | $0.348B | 0.00 |
| TruBridge (TBRG) | United States | $0.328B | 15.06 |
| Senseonics Holdings (SENS) | United States | $0.291B | 0.00 |
| KORU Medical Systems (KRMD) | United States | $0.273B | 0.00 |
| Insight Molecular Diagnostics (IMDX) | United States | $0.204B | 0.00 |
| Health Catalyst (HCAT) | United States | $0.174B | 0.00 |
| Nyxoah SA (NYXH) | Belgium | $0.173B | 0.00 |
| MDxHealth SA (MDXH) | Belgium | $0.162B | 0.00 |
| CareCloud (CCLD) | United States | $0.125B | 6.84 |
| Outset Medical (OM) | United States | $0.101B | 0.00 |
| EUDA Health Holdings (EUDA) | Singapore | $0.092B | 0.00 |
| HeartBeam (BEAT) | United States | $0.088B | 0.00 |
| Pulmonx (LUNG) | United States | $0.082B | 0.00 |
| American Well (AMWL) | United States | $0.081B | 0.00 |
| Retrieve Medical Holdings (RMHI) | United States | $0.068B | 0.00 |
| NetraMark Holdings (AINMF) | Canada | $0.067B | 0.00 |
| Precipio (PRPO) | United States | $0.046B | 0.00 |
| Evaxion - (EVAX) | Denmark | $0.043B | 0.00 |
| 111 (YI) | China | $0.032B | 0.00 |
| Lunai Bioworks (LNAI) | United States | $0.022B | 0.00 |
| P3 Health Partners (PIII) | United States | $0.021B | 0.00 |
| Predictive Oncology (POAI) | United States | $0.020B | 0.00 |
| Zhongchao (ZCMD) | China | $0.014B | 0.00 |
| HeartSciences (HSCS) | United States | $0.010B | 0.00 |
| Bullfrog AI Holdings (BFRG) | United States | $0.008B | 0.00 |
| Strata Skin Sciences (SSKN) | United States | $0.008B | 0.00 |
| PROFUSA (PFSA) | United States | $0.008B | 0.00 |
| Movano (MOVE) | United States | $0.006B | 0.00 |
| Healthcare Triangle (HCTI) | United States | $0.003B | 0.00 |
| Tivic Health Systems (TIVC) | United States | $0.002B | 0.00 |
| Mobile-health Network Solutions (MNDR) | Singapore | $0.001B | 0.00 |